Your gift is 100% tax deductible.
Stages of Soft Tissue Sarcomas
After someone is diagnosed with a soft tissue sarcoma, doctors will try to figure out if it has spread, and if so, how far. This process is called staging.
The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Cancers with similar stages tend to have a similar outlook and are often treated in much the same way.
How is the stage determined?
The stages of soft tissue sarcomas range from stages I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. And within a stage, an earlier letter means a lower stage.
TNM system
The staging system most often used for soft tissue sarcomas is the American Joint Committee on Cancer (AJCC) TNM system, which is based on 4 key pieces of information:
- The extent of the tumor (T): How large is the cancer?
- The spread to nearby lymph nodes (N): Has the cancer spread to nearby lymph nodes?
- The spread (metastasis) to distant sites (M): Has the cancer spread to distant organs such as the lungs?
- The grade (G) of the cancer: How much do the sarcoma cells look like normal cells?
Grade
The grade is partly used to determine the stage of a sarcoma. The staging system divides sarcomas into 3 grades (1 to 3) based on features seen under a microscope.
Low-grade tumors tend to be slow-growing, slower to spread, and often have a better outlook (prognosis) than higher-grade tumors.
French (FNCLCC) system
The grade of a sarcoma is determined using a system known as the French or FNCLCC system, and is based on 3 factors.
Differentiation: Cancer cells are given a score of 1 to 3. Cells assigned a 1 look a lot like normal cells and cells assigned a 3 look very abnormal. Certain types of sarcoma, like synovial and embryonal sarcomas, are given a higher score automatically.
Mitotic count: A score 1 to 3 is given to describe how many cancer cells are seen dividing. A lower score means fewer cells were seen dividing.
Tumor necrosis: A score from 0 to 2 is given to describe how much of the tumor is made up of dying tissue. A lower score means there was less dying tissue present.
After each factor is given a score, the scores are added to determine the grade of the tumor. Here's what the grade numbers mean:
- GX: The grade cannot be assessed because of incomplete information.
- Grade 1 (G1): Total score of 2 or 3
- Grade 2 (G2): Total score of 4 or 5
- Grade 3 (G3): Total score of 6, 7, or 8
Pathologic vs. clinical stage
The staging system in the table below uses the pathologic stage, also called the surgical stage. It is determined by examining tissue removed during an operation.
Sometimes, if surgery is not possible right away or at all, the cancer will be given a clinical stage instead. This is based on the results of a physical exam, biopsy, and imaging tests. The clinical stage will be used to help plan treatment.
Sometimes, the cancer has spread further than the clinical stage estimates and might not predict the patient’s outlook as accurately as a pathologic stage.
Stage grouping
There are different staging systems for soft tissue sarcomas depending on where the cancer is in the body:
- Head and neck
- Trunk and extremities (arms and legs)
- Abdomen and thoracic (chest) visceral organs
- Retroperitoneum
Once a person’s T, N, M, and G categories have been determined, this information is combined in a process called stage grouping to assign an overall stage.
Of the 4 main locations, only Trunk and Extremities and Retroperitoneum have stage groupings.
The system described below is the most recent AJCC system. Cancer staging can be complex, so ask your doctor to explain it to you in a way you understand. For more information see Cancer Staging.
Trunk and Extremities Sarcoma Stages
IA
Stage grouping: T1, N0, M0, G1 or Gx
The cancer is 5 cm or smaller (T1).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 1 (G1) or the grade cannot be assessed (GX).
IB
T2-4, N0, M0, G1 or GX
The cancer is:
- Larger than 5 cm but not more than 10 cm (T2) OR
- Larger than 10cm but not more than 15 cm (T3) OR
- Larger than 15 cm (T4).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is G1 or GX.
T1, N0, M0, G2 or G3
The cancer is 5 cm or smaller (T1).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).
IIIA
T2, N0, M0, G2 or G3
The cancer is larger than 5 cm but not more than 10 cm (T2).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).
IIIB
T3-4, N0, M0, G2 or G3
The cancer is:
- Larger than 10 cm but not more than 15 cm (T3) OR
- Larger than 15 cm (T4).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is G2 or G3.
Any T, Any N, M0, Any G
The cancer is any size (Any T) AND it has spread to nearby lymph nodes (N1).
It has not spread to distant sites (M0). It can be any grade.
Any T, Any N, M1, Any G
The cancer is any size (Any T) AND it might or might not have spread to nearby lymph nodes (Any N).
It has spread to distant sites such as the lungs (M1). It can be any grade.
Retroperitoneum Sarcoma Stages
IA
Stage grouping: T1, N0, M0, G1 or Gx
The cancer is 5 cm or smaller (T1).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 1 (G1) or the grade cannot be assessed (GX).
IB
T2-4, N0, M0, G1 or GX
The cancer is:
- Larger than 5 cm but not more than 10 cm (T2) OR
- Larger than 10cm but not more than 15 cm (T3) OR
- Larger than 15 cm (T4).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is G1 or GX.
T1, N0, M0, G2 or G3
The cancer is 5 cm or smaller (T1).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).
IIIA
T2, N0, M0, G2 or G3
The cancer is larger than 5 cm but not more than 10 cm (T2).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).
IIIB
T3-4, N0, M0, G2 or G3
The cancer is:
- Larger than 10 cm but not more than 15 cm (T3) OR
- Larger than 15 cm (T4).
It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is G2 or G3.
OR
Any T, N1, M0, Any G
The cancer is any size (Any T) AND it has spread to nearby lymph nodes (N1).
It has not spread to distant sites (M0). It can be any grade.
Any T, Any N, M1, Any G
The cancer is any size (Any T) AND it might or might not have spread to nearby lymph nodes (Any N).
It has spread to distant sites such as the lungs (M1). It can be any grade.
*The following categories are not listed in the staging groupings above:
- TX: Main tumor cannot be assessed due to lack of information.
- T0: No evidence of a primary tumor.
- NX: Regional lymph nodes cannot be assessed due to lack of information.
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
American Joint Committee on Cancer. Soft Tissue Sarcoma of the Trunk and Extremities. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017:507.
American Joint Committee on Cancer. Soft Tissue Sarcoma of the Retroperitoneum. In: AJCC Cancer Staging Manual. 8 th ed. New York, NY: Springer; 2017:531.
Last Revised: February 9, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.


